Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „pomalidomide“
Suchtreffer
Begriffe & Kennungen
Pomalidomide Teva · 4.8 · Neutropenia and thrombocytopenia tended to occur more frequently within the first 2 cycles of treatment with p
Eintrag öffnenPomalidomide Teva · 4.8 · Paediatric population Adverse reactions reported in paediatric patients (aged 4 to 18 years) with recurrent or
Eintrag öffnenPomalidomide Teva · 4.8 · Peripheral neuropathy - Pomalidomide in combination with bortezomib and dexamethasone Patients with ongoing pe
Eintrag öffnenPomalidomide Teva · 4.8 · Peripheral neuropathy - Pomalidomide in combination with dexamethasone Patients with ongoing peripheral neurop
Eintrag öffnenPomalidomide Teva · 4.8 · Pomalidomide in combination with bortezomib and dexamethasone The most commonly reported blood and lymphatic s
Eintrag öffnenPomalidomide Teva · 4.8 · Pomalidomide in combination with dexamethasone The most commonly reported adverse reactions in clinical studie
Eintrag öffnenPomalidomide Teva · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenPomalidomide Teva · 4.8 · Summary of the safety profile
Eintrag öffnenPomalidomide Teva · 4.8 · Table 7. Adverse reactions(ADRs) reported in clinical trials and post-market settings Combination of Pomalidom
Eintrag öffnenPomalidomide Teva · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenPomalidomide Teva · 4.8 · Teratogenicity Pomalidomide is structurally related to thalidomide. Thalidomide is a known human teratogenic a
Eintrag öffnenPomalidomide Teva · 4.8 · The adverse reactions observed in patients treated with pomalidomide in combination with bortezomib and dexame
Eintrag öffnenPomalidomide Teva · 4.8 · The frequencies in this section are from clinical studies in patients receiving pomalidomide treatment in comb
Eintrag öffnenPomalidomide Teva · 4.8 · Thrombocytopenia occurred in 39.9% (Pom+Btz+Dex) patients and 27.0% (Pom+Dex) patients. Thrombocytopenia was G
Eintrag öffnenPomalidomide Teva · 4.8 · Thromboembolic events Prophylaxis with acetylsalicylic acid (and other anticoagulants in high risk patients) w
Eintrag öffnenPomalidomide Teva · 4.8 · Venous thromboembolic events (VTE) occurred in 12.2% (Pom+Btz+Dex) and 3.3% (Pom+Dex) patients (5.8 % (Pom+Btz
Eintrag öffnenPomalidomide Zentiva
Eintrag öffnenPomalidomide Zentiva · 4.1 Therapeutic indications · 1
Eintrag öffnenPomalidomide Zentiva · 4.3 Contraindications · 1
Eintrag öffnenPomalidomide Zentiva · 4.3 · • Pregnancy. • Women of childbearing potential, unless all the conditions of the pregnancy prevention programm
Eintrag öffnen